Digital Health Solutions for Chronic Conditions Market Report 2026

The digital health solutions for chronic conditions market size has grown rapidly in recent years. It will grow from $270.14 billion in 2025 to $317.86 billion in 2026 at a compound annual growth rate (CAGR) of 17.7%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, rising healthcare costs associated with long-term conditions, expansion of mobile health applications, growing use of connected medical devices, early adoption of telehealth services.

The digital health solutions for chronic conditions market size is expected to see rapid growth in the next few years. It will grow to $603.39 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to growing demand for value-based chronic care, rising investments in ai-driven care personalization, expansion of home-based healthcare models, increasing integration of digital therapeutics, stronger focus on long-term patient engagement and outcomes. Major trends in the forecast period include expansion of remote patient monitoring solutions, growing adoption of personalized care platforms, increased use of predictive analytics for chronic care, rising integration of wearables and connected devices, enhanced focus on continuous care management.

The increasing prevalence of diabetes is expected to drive the growth of the digital health solutions for chronic conditions market in the coming years. Diabetes is a long-term metabolic disorder in which the body either fails to produce sufficient insulin or cannot effectively use the insulin it produces. The rise in diabetes cases is largely attributed to sedentary lifestyles, as lower levels of physical activity contribute to obesity and insulin resistance. Digital health solutions support diabetes management by enabling real-time blood glucose monitoring, allowing patients to continuously track fluctuations and make timely adjustments to their diet, medication, or lifestyle to achieve better blood sugar control. For example, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-profit organization, 589 million people were living with diabetes in 2024, and this figure is projected to rise to 853 million by 2050. Consequently, the growing prevalence of diabetes is fueling the expansion of the digital health solutions for chronic conditions market.

Leading companies in the digital health solutions for chronic conditions market are concentrating on the development of advanced approaches, such as real-time injection monitoring, to enhance treatment precision, patient adherence, and overall disease management. Real-time injection monitoring involves digital systems that track and document medication administration as it occurs, offering patients and healthcare providers timely insights to optimize dosing, ensure compliance, and minimize the risk of complications. For instance, in April 2025, Ypsomed Holding AG, a Switzerland-based developer of injection and infusion systems, partnered with Sidekick Health, an Iceland-based digital therapeutics provider, to launch a collaborative digital health solution for obesity management. This solution integrates Ypsomed’s connected devices with Sidekick’s digital therapeutics platform to deliver personalized, data-driven care for individuals managing obesity. It incorporates continuous monitoring, behavior change support, and lifestyle coaching to improve treatment adherence and long-term health outcomes. By combining connected medical technologies with digital therapeutics, the collaboration aims to increase patient engagement and provide comprehensive support throughout the obesity management process.

In July 2025, Samsung Electronics Co. Ltd., a South Korea-based electronics and information technology company, acquired Xealth for an undisclosed amount. Through this acquisition, Samsung seeks to close the gap between wellness and medical care by embedding digital health capabilities into its broader ecosystem, enabling more personalized care management and improved patient engagement. Xealth is a US-based provider of digital health solutions for chronic conditions.

Major companies operating in the digital health solutions for chronic conditions market are ResMed Inc., Teladoc Health Inc., Noom Inc., Personify Health Inc., Biofourmis Inc., Vida Health Inc., Virta Health Inc., Omada Health Inc., Mahalo Health Inc., DarioHealth Corp., Sidekick Health Inc., WellDoc Inc., Lark Health Inc., Voluntis Inc., One Drop Inc., Kaia Health Software GmbH, CureApp Inc., Riva Health Inc., Sweetch-Health Ltd., Canary Health Inc.

North America was the largest region in the digital health solutions for chronic conditions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital health solutions for chronic conditions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital health solutions for chronic conditions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the digital health solutions for chronic conditions market by increasing costs of imported wearable devices, sensors, connected medical hardware, cloud infrastructure components, and analytics platforms. Healthcare providers and homecare solution vendors in North America and Europe are most affected due to reliance on imported digital health hardware, while Asia-Pacific faces higher costs for device manufacturing and deployment. These tariffs are raising solution pricing and slowing adoption in cost-sensitive markets. However, they are also encouraging local device manufacturing, regional software innovation, and domestic digital health ecosystem development that supports sustainable chronic care delivery.

The digital health solutions for chronic conditions market research report is one of a series of new reports that provides digital health solutions for chronic conditions market statistics, including digital health solutions for chronic conditions industry global market size, regional shares, competitors with a digital health solutions for chronic conditions market share, detailed digital health solutions for chronic conditions market segments, market trends and opportunities, and any further data you may need to thrive in the digital health solutions for chronic conditions industry. This digital health solutions for chronic conditions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital health solutions for chronic conditions are technology-enabled tools developed to monitor, manage, and support individuals living with long-term illnesses. They utilize digital platforms, mobile applications, and connected devices to track health indicators, deliver personalized care guidance, and enable communication between patients and healthcare providers. These solutions are intended to improve treatment adherence, enhance quality of life, and lower the risk of complications associated with chronic diseases.

The primary types of digital health solutions for chronic conditions include diabetes, cardiovascular diseases, chronic respiratory diseases, and others. Diabetes is a long-term medical condition in which the body cannot effectively produce or utilize insulin, leading to increased blood glucose levels. These solutions are applied across enterprise and personal settings and are used by a range of end users, including payers and employers, hospitals and clinics, pharmaceutical and life sciences companies, homecare environments, and patients and caregivers.

The digital health solutions for chronic conditions market consists of revenues earned by entities by providing services such as remote patient monitoring, teleconsultation, disease management programs, medication adherence support, and health coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital health solutions for chronic conditions market also includes sales of wearable health trackers, glucose monitors, blood pressure monitors, smart inhalers, pulse oximeters, connected scales, continuous glucose monitoring devices, smart medication dispensers, and fitness bands. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.